SCHEDULE: BlackRock Discloses 15.1% Stake in CONMED Corp

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.1% beneficial ownership stake in CONMED Corp's common stock as of June 30, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 4,679,441 shares of CONMED Corp common stock.
• This ownership represents 15.1% of the total outstanding common stock of CONMED Corp.
• BlackRock holds sole voting power over 4,603,877 shares and sole dispositive power over 4,679,441 shares.
• The filing is an Amendment No. 20 to a Schedule 13G, indicating ongoing reporting of BlackRock's stake.
• The securities are held in the ordinary course of business and not for the purpose of changing or influencing control of CONMED Corp.
• iShares Core S&P Small-Cap ETF, a subsidiary of BlackRock, holds more than 5% of CONMED Corp's common stock.

Sentiment

Score: 5

Explanation: The document is a standard Schedule 13G amendment disclosing a passive ownership stake by BlackRock in CONMED Corp. It does not contain information about CONMED's financial performance, strategic direction, or any events that would typically indicate positive or negative sentiment.

Positives

• Significant institutional investment from BlackRock, a major global asset manager, indicates confidence in CONMED Corp.
• BlackRock's passive investment stance, not seeking to influence control, suggests stability in the ownership structure.

Negatives

• No specific negatives related to CONMED Corp's performance or operations are disclosed in this ownership filing.

Risks

• No specific risks related to CONMED Corp's operations or financial health are detailed in this ownership disclosure. The filing is solely about BlackRock's beneficial ownership.

Future Outlook

This Schedule 13G filing does not provide any forward-looking statements or guidance regarding CONMED Corp's future performance or outlook.

Management Comments

• Spencer Fleming, Managing Director of BlackRock, Inc., certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This Schedule 13G filing indicates that BlackRock, one of the world's largest asset managers, maintains a significant passive ownership stake in CONMED Corp. Such filings are common for large institutional investors who hold more than 5% of a company's stock for investment purposes, rather than to exert control. This type of filing provides transparency regarding major institutional holdings in publicly traded companies, which is a standard practice in the financial industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially signaling long-term institutional interest.
• Management: Awareness of a large, passive institutional investor on the shareholder register.

Next Steps

• CONMED Corp will continue its operations.
• BlackRock, Inc. will continue to monitor its investment and file future amendments to Schedule 13G as required by changes in its beneficial ownership.

Key Dates

Keywords

CONMED Corp, BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Asset Management, SEC Filing